HealthBank posts FY2025 net loss of RMB3.3 million (60%)

Reuters
02/26
HealthBank posts FY2025 net loss of RMB3.3 million (60%)

HealthBank (HealthBank Holdings Ltd.) reported FY2025 revenue of CNY 0.14 million (26% YoY) and a net loss of CNY 3.29 million (60% YoY), according to its unaudited results for the year ended 31 December 2025. For 2HY25, revenue was CNY 0.11 million (26% YoY) and net loss was CNY 2.27 million (67% YoY). The FY2025 loss attributable to equity holders was CNY 3.23 million (60% YoY), with basic/diluted loss per share of 3.37 RMB cents (FY2025). As at 31 December 2025, HealthBank reported cash and bank balances of CNY 1.68 million, financial assets at fair value through profit or loss (FVTPL) of CNY 13.16 million, total assets of CNY 15.00 million, total liabilities of CNY 0.93 million and net assets of CNY 14.07 million. NAV per share was RMB 0.14 (31-Dec-25). Management said FY2025 revenue was generated from ad hoc consulting services provided by Hainan Zhongyuan Cultural Tourism Co., Ltd., and the revenue decline was attributed to reduced consulting work. Other income rose to CNY 0.12 million (more than 2x YoY), mainly due to reimbursement for Government-Paid Maternity Leave. Other losses were mainly driven by a CNY 1.46 million fair value loss on FVTPL. The group also highlighted a share placement: 7.75 million new shares were issued in October 2025 (Tranche 1), and a further 7.75 million shares were issued on 19 January 2026 (Tranche 2), taking issued shares to 109.80 million as at the announcement date; net proceeds from the placement were SGD 0.41 million, with SGD 0.15 million utilised as of the announcement date for working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthBank Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 5I2KB23I1ITUHI4E) on February 26, 2026, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10